Achaogen
develops and commercializes novel antibacterials to treat the multi-drug resistant gram-negative infections... Read moreAchaogen
develops and commercializes novel antibacterials to treat the multi-drug resistant gram-negative infections... Read more
News
Feb 20, 2020
PR Newswire Asia
Press Release: Achaogen : Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region
Jan 28, 2020
Global Legal Chronicle
Achaogen: Achaogen, Inc.'s Bankruptcy Sale To Xuanzhu Biopharmaceutical Ltd.
Jul 26, 2019
Business Medical Dialogues
Achaogen: Cipla arm acquires anti-infective Zemdri from Achaogen to treat cUTI
Jun 07, 2019
BioPortfolio
Achaogen: Achaogen Inc. Announces Results of Auction for Substantially All Company Assets
Apr 24, 2019
Pharamceutical Technology
Achaogen: Struggling sales for antibiotics are feeding through to upcoming launches
Apr 15, 2019
BioPortfolio
Achaogen: Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval
Mar 28, 2019
GlobeNewswire
Press Release: Achaogen : Achaogen Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Feb 28, 2019
BioPharma Dive
Achaogen: Hurdles of antibiotic R&D on display in Achaogen's divergent study outcomes
Feb 20, 2019
GlobeNewswire
Press Release: Achaogen : Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences
Feb 15, 2019
4-traders
Achaogen: Achaogen Announces Pricing of $15 Million Underwritten Public Offering
Achaogen Competitors
1
2
3
4
5
6
7
8
9
10